ATE285789T1 - Mukosale zytotoxische t-lymphozytenantwort - Google Patents
Mukosale zytotoxische t-lymphozytenantwortInfo
- Publication number
- ATE285789T1 ATE285789T1 AT98946965T AT98946965T ATE285789T1 AT E285789 T1 ATE285789 T1 AT E285789T1 AT 98946965 T AT98946965 T AT 98946965T AT 98946965 T AT98946965 T AT 98946965T AT E285789 T1 ATE285789 T1 AT E285789T1
- Authority
- AT
- Austria
- Prior art keywords
- lymphocyte response
- mucosal
- cytotoxic
- mucosal cytotoxic
- pathogens
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5852397P | 1997-09-11 | 1997-09-11 | |
US7489498P | 1998-02-17 | 1998-02-17 | |
PCT/US1998/019028 WO1999012563A2 (en) | 1997-09-11 | 1998-09-11 | Mucosal cytotoxic t lymphocyte responses |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE285789T1 true ATE285789T1 (de) | 2005-01-15 |
Family
ID=26737711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98946965T ATE285789T1 (de) | 1997-09-11 | 1998-09-11 | Mukosale zytotoxische t-lymphozytenantwort |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1011720B1 (de) |
JP (1) | JP2001515869A (de) |
AT (1) | ATE285789T1 (de) |
AU (1) | AU757310B2 (de) |
CA (1) | CA2303410A1 (de) |
DE (1) | DE69828414T2 (de) |
ES (1) | ES2236941T3 (de) |
PT (1) | PT1011720E (de) |
WO (1) | WO1999012563A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000051980A1 (en) | 1999-03-05 | 2000-09-08 | The Procter & Gamble Company | C16 unsaturated fp-selective prostaglandins analogs |
ES2320971T3 (es) * | 1999-10-12 | 2009-06-01 | National Research Council Of Canada | Arqueosomas como adjuvantes y vehiculos para vacunas acelulares para inducir respuestas de linfocitos t cototoxicos. |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US6368602B1 (en) * | 2000-06-16 | 2002-04-09 | Hadasit Medical Research Services And Development Ltd | Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
DE10154579A1 (de) * | 2001-11-07 | 2003-05-28 | Medigene Ag | Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen |
GB0224415D0 (en) * | 2002-10-21 | 2002-11-27 | Medical Res Council | Compositions |
BRPI0504117A (pt) | 2005-09-05 | 2007-05-22 | Fundacao De Amparo A Pesquisa | epìtopos, combinação de epìtopos, usos de epìtopos ou sua combinação, composição, usos da composição, vacinas profiláticas anti-hiv-1, vacinas terapêuticas, método para a identificação de epìtopos e métodos para o tratamento ou prevenção |
US20120177668A1 (en) * | 2009-07-06 | 2012-07-12 | The Australian National University | Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294322B1 (en) * | 1988-01-26 | 2001-09-25 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
-
1998
- 1998-09-11 EP EP98946965A patent/EP1011720B1/de not_active Expired - Lifetime
- 1998-09-11 PT PT98946965T patent/PT1011720E/pt unknown
- 1998-09-11 AU AU93862/98A patent/AU757310B2/en not_active Ceased
- 1998-09-11 DE DE69828414T patent/DE69828414T2/de not_active Expired - Lifetime
- 1998-09-11 WO PCT/US1998/019028 patent/WO1999012563A2/en active IP Right Grant
- 1998-09-11 AT AT98946965T patent/ATE285789T1/de not_active IP Right Cessation
- 1998-09-11 ES ES98946965T patent/ES2236941T3/es not_active Expired - Lifetime
- 1998-09-11 CA CA002303410A patent/CA2303410A1/en not_active Abandoned
- 1998-09-11 JP JP2000510460A patent/JP2001515869A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2236941T3 (es) | 2005-07-16 |
DE69828414D1 (de) | 2005-02-03 |
EP1011720A2 (de) | 2000-06-28 |
WO1999012563A3 (en) | 1999-05-27 |
DE69828414T2 (de) | 2005-12-01 |
AU9386298A (en) | 1999-03-29 |
PT1011720E (pt) | 2005-04-29 |
JP2001515869A (ja) | 2001-09-25 |
AU757310B2 (en) | 2003-02-13 |
CA2303410A1 (en) | 1999-03-18 |
EP1011720B1 (de) | 2004-12-29 |
WO1999012563A2 (en) | 1999-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL1002372A1 (nl) | Halfgeleider licht-emitterende inrichting en werkwijze voor het produceren van deze. | |
DE69527924D1 (de) | Hitzebeständige xylanasen | |
TW278099B (de) | ||
IL147618A0 (en) | Method for treating chronic pain using mek inhibitors | |
EP0861539A4 (de) | Effiziente kryptographische hash-funktionen und verfahren zur vergrösserung der sicherheit der hash-funktionen und der pseudozufallsfunktionen | |
DE69525369D1 (de) | Kontinuierliches polymerisationverfahren von polyamiden | |
MXPA02001911A (es) | Anticuerpos ctla-4 humanos y sus usos. | |
DE60142794D1 (de) | Antikörper gegen cd28 | |
ES2090641T3 (es) | Sellado de cables. | |
GB9716675D0 (en) | Epitaxial wafer for light-emitting device,method of forming the wafer and light-emitting device using the wafer | |
DK73291A (da) | Fremgangsmaade til opvarmning af en transportroerledning samt transportroerledning forsynet med opvarmningsmidler | |
GB2291733B (en) | Security device | |
DE69828414D1 (de) | Mukosale zytotoxische t-lymphozytenantwort | |
ATE262342T1 (de) | Substance p behandlung zur immunostimulierung | |
ATE180350T1 (de) | Klemmeinrichtung und zugehörige halteeinrichtung | |
HN1997000162A (es) | Metodo y aparato para el procesamiento de tabaco | |
BG102395A (en) | New phenylamidine derivatives, method for their preparation and application as medicamentous forms | |
BR9303606A (pt) | Processo e aparelho de adensar um artigo. | |
SE9604581D0 (sv) | An agent against cancer and virus infections | |
DE69821173D1 (de) | Elektronenemittierende Vorrichtung, Elektronenquelle und Bilderzeugungsgerät | |
IT1299948B1 (it) | Metodo e dispositivo per la formazione di gruppi di articoli appiattiti. | |
PL331882A1 (en) | Substituted 1,2,3,4-tetrahydro-2-dibenzofurane amines and 2-amino cyclohepta[b]benzofuranes | |
ATE215084T1 (de) | Imidazopyridin-azolidinone | |
EP0637086A3 (de) | Lichtemitierendes Halbleiterbauelement und lichtunterstütztes Abscheideverfahren zu seiner Herstellung. | |
MX9804043A (es) | Composiciones parasiticidas a base de polisiloxanos ciclicos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |